Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone in Adults With Non-Alcoholic Steatohepatitis
NCT04669158Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jul 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of idebenone in Nonalcoholic steatohepatitis (NASH), sponsored by Stanford University. Started Jul 2021; status: completed.
02
Drugs
idebenone
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04669158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04669158.